The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas.

Dogansen, Sema; Selcukbiricik, ÖZLEM; Bilir, Betul; Yarman, Emine

doi:10.1016/j.ghir.2016.04.004

The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas.

Dogansen S. C., Selcukbiricik Ö., Bilir B. E., Yarman S.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, vol.29, pp.45-49, 2016 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 29
Publication Date: 2016
Doi Number: 10.1016/j.ghir.2016.04.004
Journal Name: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.45-49
Keywords: Autoimmune thyroid disease, Hashimoto's thyroiditis, Prolactinoma, Hyperprolactinemia, Somatotrophinoma, Acromegaly, CLINICAL-PRACTICE GUIDELINE, GROWTH-HORMONE, HASHIMOTOS-THYROIDITIS, CANCER-RISK, HYPERPROLACTINEMIA, SOCIETY, CELLS, GLAND, BROMOCRIPTINE, ACTIVATION
Istanbul University Affiliated: Yes

Abstract

Objective: Many studies have shown that prolactin (PRL) plays an important role in autoimmune diseases. The aim of this study was to compare the current frequency of autoimmune thyroid disease (ATD) in prolactinomas with another type of functional pituitary adenoma (FPA), somatotrophinoma. Another aim of the study was to evaluate possible factors related to thyroid autoimmunity and, the process of ATD in FPAs.